ArticleBrain, behavior, & immunity - health2024

Low-dose naltrexone and NAD+ for the treatment of patients with persistent fatigue symptoms after COVID-19.

Anar Isman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.